| Literature DB >> 30572686 |
Yuan-Ming Zhou1,2, Guang-Lin Ju3, Lin Xiao4, Xiang-Fei Zhang5, Feng-Yu Du6,7.
Abstract
On the basis of the 'one strain, many compounds' (OSMAC) strategy, chemical investigation of the marine-derived fungus Trichothecium roseum resulted in the isolation of trichomide cyclodepsipeptides (compounds 1⁻4) from PDB medium, and destruxin cyclodepsipeptides (compounds 5⁻7) and cyclonerodiol sesquiterpenes (compounds 8⁻10) from rice medium. The structures and absolute configurations of novel (compounds 1, 8, and 9) and known compounds were elucidated by extensive spectroscopic analyses, X-ray crystallographic analysis, and ECD calculations. All isolated compounds were evaluated for cytotoxic, nematicidal, and antifungal activities, as well as brine shrimp lethality. The novel compound 1 exhibited significant cytotoxic activities against the human cancer cell lines MCF-7, SW480, and HL-60, with IC50 values of 0.079, 0.107, and 0.149 μM, respectively. In addition, it also showed significant brine shrimp lethality, with an LD50 value of 0.48 μM, and moderate nematicidal activity against Heterodera avenae, with an LC50 value of 94.9 μg/mL. This study constitutes the first report on the cytotoxic and nematicidal potential of trichomide cyclodepsipeptides.Entities:
Keywords: cyclodepsipeptides; cytotoxic activity; marine-derived fungus; nematicidal activity; sesquiterpenes
Mesh:
Substances:
Year: 2018 PMID: 30572686 PMCID: PMC6316070 DOI: 10.3390/md16120519
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Compounds 1–4 from the liquid PDB medium, 5–10 from the solid rice medium, and the reference Compound 11 (cyclonerodiol).
1H (500 MHz) and 13C (125 MHz) NMR data of compound 1 (CD3OD, δ: ppm).
| No. | No. | ||||
|---|---|---|---|---|---|
| CO | 170.4, C | CO | 172.1, C | ||
|
| 70.7, CH | 5.21, t (7.0) |
| 56.9, CH | 5.09, d (11.0) |
|
| 34.9, CH2 | 2.18, m |
| 33.4, CH | 2.06, m |
|
| 67.2, CH | 3.82, m | 14.8, CH3 | 0.90, overlapped | |
|
| 48.3, CH2 | 3.61, d (5.0) |
| 25.3, CH2 | 1.50, m; 1.07, m |
|
| 10.0, CH3 | 0.94, overlapped | |||
| CO | 172.4, C | 30.1, CH3 | 3.21, s | ||
|
| 67.5, CH | 4.08, m | |||
|
| 37.5, CH | 2.55, m | CO | 170.8, C | |
|
| 30.6, CH2 | 2.10, m; 1.77, br s |
| 55.4, CH | 5.32, q (6.5) |
|
| 45.4, CH2 | 4.06, m; 3.95, m |
| 14.3, CH3 | 1.32, overlapped |
| 17.9, CH3 | 1.16, d (6.8) | 27.5, CH3 | 2.71, s | ||
| Ile3 | |||||
| CO | 173.6, C | CO | 173.6, C | ||
|
| 53.4, CH | 4.76, overlapped |
| 33.8, CH2 | 2.69, m; 2.58, m |
|
| 37.0, CH | 1.94, m |
| 33.4, CH2 | 3.80, m; 3.15, m |
| 14.3, CH3 | 0.86, overlapped |
| 8.56, br. s | ||
|
| 24.6, CH2 | 1.49, m;1.33, overlapped | |||
|
| 9.7, CH3 | 0.87, overlapped | |||
|
| 7.03, d (7.8) |
Figure 2The key 1H–1H COSY (blue bond lines) and HMBC (red arrows) correlations of 1, 8, and 9. measured in DMSO-d6.
Figure 3X-ray crystal structure of compound 1.
1H (500 MHz) and 13C (125 MHz) NMR data of compounds 8 and 9 (δ: ppm) a.
| Compound 8 | Compound 9 | ||||
|---|---|---|---|---|---|
| No. | No. | ||||
| 1 | 14.0, CH3 | 1.05 (6.6) | 1 | 14.5, CH3 | 1.05 (6.8) |
| 2 | 44.1, CH | 1.57, m | 2 | 44.3, CH | 1.61, m |
| 3 | 80.7, C | 3 | 81.4, C | ||
| 4 | 40.0, CH2 | 1.63, m; 1.55, m | 4 | 40.4, CH2 | 1.68, m; 1.53, m |
| 5 | 23.8, CH2 | 1.85, m; 1.60, m | 5 | 24.4, CH2 | 1.86, m; 1.61, m |
| 6 | 54.1, CH | 1.87, m | 6 | 54.2, CH | 1.86, m |
| 7 | 74.1, C | 7 | 74.5, C | ||
| 8 | 40.0, CH2 | 1.52, t (8.4) | 8 | 43.4, CH2 | 2.20, m |
| 9 | 22.0, CH2 | 2.13, m | 9 | 122.1, CH | 5.70, overlapped |
| 10 | 129.6, CH | 5.47, t (7.0) | 10 | 142.3, CH | 5.70, overlapped |
| 11 | 129.9, C | 11 | 70.8, C | ||
| 12 | 69.9, CH2 | 4.45, s | 12 | 29.9, CH3 | 1.33, s |
| 13 | 24.7, CH3 | 1.26, s | 13 | 26.1, CH3 | 1.25, s |
| 14 | 23.2, CH3 | 1.17, s | 14 | 25.2, CH3 | 1.13, s |
| 15 | 12.5, CH3 | 1.67, s | 15 | 29.9, CH3 | 1.33, s |
| COCH3 | 19.4, CH3 | 2.08, s | |||
| C=O | 171.5, C | ||||
a 8 and 9 were determined using CDCl3 and CD3OD, respectively.
Figure 4Key NOE correlations of compound 8.
Figure 5Plausible biosynthetic pathways of cyclonerodiol sesquiterpenes, compounds 8–10.
Cytotoxicity of the new compound 1 against five human cancer cell lines (IC50: μM).
| Compound | MCF-7 | SW480 | HL-60 | A-549 | SMMC-7721 |
|---|---|---|---|---|---|
| 1 | 0.079 ± 0.004 | 0.107 ± 0.015 | 0.149 ± 0.007 | >40 | >40 |
| Cisplatin | 19.44 ± 1.57 | 20.80 ± 1.04 | 3.72 ± 0.09 | 16.97 ± 0.69 | 12.35 ± 0.52 |
Brine shrimp lethality (LD50, μM) and nematicidal activity (LC50, μg/mL) of compounds 1–10.
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Positive Control | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| brine shrimp lethality | 0.48 | 0.74 | >50 | 3.22 | 2.47 | 2.81 | >50 | n.a. | n.a. | n.a. | 8.4 a |
| nematicidal activity | 94.9 | 143.6 | >500 | 221.8 | 207.7 | 293.4 | >500 | n.a. | n.a. | n.a. | 23.1 b |
n.a.: no activity. a,b colchicine for brine shrimp lethality and abamectin for the nematicidal bioassay.